ACE2 and COVID-19: Nonetheless, the ACE2 cross-reactive S1-RBD mAbs found in this study provide valuable reagents to address the contribution of these ACE2 cross-reactive S1-RBD antibodies in the immunopathogenesis of COVID-19 during SARS-CoV-2 infection in the future.